I followup recommendations Part 3: common hematologic malignancies

Malcolm L. Brigden(University of Saskatchewan), David P. Sheridan, Shahid Ahmed(Emory University)
Unknown
January 1, 2011
Cited by 1

Related Papers

Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management
|Cancers|2023|640
Gallbladder Cancer in the 21st Century
|Journal of Oncology|2015|301
HER2-directed therapy: current treatment options for HER2-positive breast cancer
|Breast Cancer|2015|183
Diabetes and Cancer: Risk, Challenges, Management and Outcomes
|Cancers|2021|183
Current status of immunotherapy in metastatic colorectal cancer
|International Journal of Colorectal Disease|2018|149